Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AC-7739 possesses cytotoxic and proapoptotic effects in MDR leukemia cell lines

Dec. 11, 2001

Full analysis of phase II data confirm efficacy of BBR-2778 in advanced NHL

Dec. 11, 2001

Apoptotic effects of HA-14-1 characterized in leukemia and lymphoid cells

Dec. 11, 2001

Patients with refractory or relapsed acute leukemia respond to weekly BMS-214662

Dec. 11, 2001

Procyon enters cancer technology option agreement

Dec. 11, 2001

FDA lifts hold on phase III trial of Aptosyn + Taxotere

Dec. 10, 2001

Tubulin polymerization inhibitor effective against refractory tumors in clinical trials

Dec. 10, 2001

PSC-833, an MDR modulator, examined in untreated AML patients of different age groups

Dec. 10, 2001

Sugen presents in vitro data on indolinone related to SU-5416 at Hematology meeting

Dec. 10, 2001

Thioredoxin-targeting class of antitumor agents synthesized at U.K. university

Dec. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...